Director of the Tower Urology Institute of Robotic and Minimally Invasive Surgery
Urology
Dr. Matthew H. Bui, MD
|
|
Give Review
Matthew works in the field of Urology. She attended Yale University School of Medicine. Yale University School of Medicine is one of the top medical schools in the US. Yale University School of Medicine has a rank of 7 in research and a 57 in primary care She has 1 awards "CMS Meaningful Use Stage 1 Certification". Doctor Matthew H. Bui, MD has written publications. She has 31 publications published with PubMed. The lastest publication is: 'Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins.' She is registered with Medicare and accepts Medicare payments.
Publications
- Less smoke and minimal tissue carbonization using a thulium laser for laparoscopic partial nephrectomy without hilar clamping in a porcine model.
- Association of bowel rest and ketorolac analgesia with short hospital stay after laparoscopic donor nephrectomy.
- Incidence of ureteral strictures after laparoscopic donor nephrectomy.
- Testicular microlithiasis, chemotherapy for stage I seminoma, and chemotherapy for advanced extragonadal germ cell tumors.
- Calyceal diverticula. Ureteroscopic management.
- Stem cell genes in androgen-independent prostate cancer.
- Case scenario: 69-year-old male with left spermatic cord mass.
- Biomarkers for early detection and optimized treatment for transitional cell carcinoma.
- Membrane association of influenza virus matrix protein does not require specific hydrophobic domains or the viral glycoproteins.
- The role of nuclear import and export in influenza virus infection.
- Prognostic factors and molecular markers for renal cell carcinoma.
- Nucleo-cytoplasmic localization of influenza virus nucleoprotein depends on cell density and phosphorylation.
- Nuclear trafficking of influenza virus ribonuleoproteins in heterokaryons.
- Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma.
- Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins.
- Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma.
- TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion.
- Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
- Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
- Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma.
- Using protein expressions to predict survival in clear cell renal carcinoma.
- Carcinoma in situ of the urinary bladder: review of clinicopathologic characteristics with an emphasis on aspects related to molecular diagnostic techniques and progno...
- Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma.
- Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma.
- Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clini...
- Paraneoplastic signs and symptoms of renal cell carcinoma: implications for prognosis.
- Current staging of renal cell carcinoma.
- LABAZ1: A metastatic tumor model for renal cell carcinoma expressing the carbonic anhydrase type 9 tumor antigen.
- Novel kidney cancer immunotherapy based on the granulocyte-macrophage colony-stimulating factor and carbonic anhydrase IX fusion gene.
- Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins.
Doctors Specialties
- Urology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
UCLA Medical Center -
Yale University School of Medicine
Hospital
-
Cedars-Sinai Medical Center
Drug Facts
| NPI NUMBER | 1578547105 | |
| NPPES Provider LastName | BUI | |
| NPPES Provider FirstName | MATTHEW | |
| NPPES Provider ZIPCode | 900486101 | |
| NPPES Provider State | CA | |
| Specialty Description | Urology | |
| Total Claim Count | 1723.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 42.0 | |
| Percent Opioid Claims | 2.44 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1578547105 |
| Last Name Of The Provider | BUI |
| First Name Of The Provider | MATTHEW |
| View All |
Similar Doctors
|
Dr. Scott Zeitlin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald G. Skinner, MD |
|
|
Dr. Dudley S. Danoff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John P. Brusky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ja-Hong Kim, MD |
|
|
Dr. Matthew D. Dunn, MD |
|
|
Dr. Gladys Y. Ng, MD
This Doctor is OpenDoctor Recommended.
|